Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (N-His)

Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein (N-His)

SKU: DRA31-50ug
Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein is produced by our E.coli expression system and the target gene encoding Met1-Ala419 is expressed with a 6His tag at the N-terminus. Bon Opus Cat.# DRA31
  • Accession Number

  • Purity

    Greater than 95% as determined by reducing SDS-PAGE.
  • Background

    Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.
  • Expression

  • Packaging

    Dry ice/ice packs
  • ALTnames

    2019-nCoV coronavirus NP Protein; 2019-nCoV np Protein; 2019-nCoV novel coronavirus Nucleoprotein Protein
  • Bioactivity

    Immobilized SARS-CoV-2 (2019-nCoV) NP Antibody (6G9)(Cat#DA027) at 5μg/ml (100 μl/well) showing the  binding to SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein-His (Cat#DRA31).

    The ED50 of SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein-His (Cat#DRA31) is 68 ng/ml.

  • Formulation

    Supplied as a 0.2 μM filtered solution of 20 mM Tris-HCl,300 mM NaCl, 1mM EDTA,pH 8.0.

  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA